Thrombin-directed inhibitors: Pharmacology and clinical use
Open Access
- 1 January 2005
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 149 (1), S54-S60
- https://doi.org/10.1016/j.ahj.2004.10.023
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Ximelagatran/MelagatranDrugs, 2004
- Prevention of Venous Thromboembolism Following Orthopaedic SurgeryDrugs, 2004
- Will direct thrombin inhibitors replace warfarin for preventing embolic events in atrial fibrillation?Current Opinion in Cardiology, 2004
- Antihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevanceBlood, 2003
- Argatroban for Prevention and Treatment of Thromboembolism in Heparin-Induced ThrombocytopeniaAnnals of Pharmacotherapy, 2001
- Recombinant Hirudin in Clinical PracticeCirculation, 2001
- Lepirudin Dosing in Dialysis‐Dependent Renal FailurePharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000
- DesirudinDrugs, 2000
- Quality of Anticoagulation Management Among Patients With Atrial FibrillationArchives of Internal Medicine, 2000
- New Anticoagulant StrategiesDrugs, 1994